Dr. David Lillicrap

Professor David Lillicrap is an internationally-renowned leader in field of Molecular Hemostasis. , His research program, focused on the molecular characterization and genetic basis of hemophilia and von Willebrand disease (VWD), has led to innovative strategies for the diagnosis and treatment of the world's most commonly-inherited bleeding diseases. His studies of hemophilia have developed and evaluated gene-based therapies for this classical recessive genetic trait, and he has made advances in characterizing the genetic mechanisms underlying the pathology of VWD. Lillicrap's novel findings, now being applied to clinical care worldwide, are improving the quality of life for patients with inherited bleeding disorders.